Beijing Sungen Biomedical Technology Co., Ltd. to Speak at ACCESS CHINA BD Forum @ BIO

June 15, 2025 (Boston) — We are glad to announce that Zhonghai Yan, Ph.D, the BD Director of Beijing Sungen Biomedical Technology Co., Ltd., will be presenting at the ACCESS CHINA BD Forum @BIO on June 15, 2025. ACCESS CHINA Biotech Forum is the largest corporate access event between Asia and the western biopharma industry.

About Beijing Sungen Biomedical Technology Co., Ltd.

Beijing Sungen Biomedical Technology Co., Ltd is an innovation-driven, clinical-stage biotechnology company founded in 2018, dedicated to advancing human health through cutting-edge technologies. We are pioneering the development of First-in-Class (FIC) and Best-in-Class (BIC) antibody-based therapeutics, including monoclonal antibodies (mAbs), bispecific antibodies (BsAbs), antibody-drug conjugates (ADCs) and Antibody-oligonucleotide conjugates (AOCs). Supported by a team of dedicated researchers and management with successful biotechnology entrepreneur experiences, Sungen has developed international level major research and manufacturing platforms in-house, such as AI-powered drug discovery platform, animal resource center (including IVD and imaging analyzing platforms), and CMC workshops. We leverage our innovative technology platforms to transform targeted therapies, focusing on cardiovascular, tumor, and neurodegenerative diseases.

It is our commitment to address critical unmet clinical needs and improve patient outcomes worldwide.

About the speaker

Zhonghai Yan, Ph.D. is a biopharma BD leader with 2+ years’ experience driving strategic partnerships in oncology. As BD Director at SunGen Biopharma, he negotiates deals spanning preclinical to commercial-stage assets, having previously led multiple CRO collaborations from target to IND. Trained at Columbia University (postdoc) and Shanghai Jiao Tong (Ph.D.), he bridges deep molecular biology expertise (25+ publications) with deal-making acumen to advance innovative therapies.

About ACCESS CHINA BD Forum @BIO

‘ACCESS CHINA BD Forum @BIO is scheduled to be held on June 15, 2025, at Seaport Boston Hotel. This year’s ACCESS CHINA BD Forum @BIO will convene 80 distinguished guests for an afternoon of strategic networking, business development, and thought leadership, with a special emphasis on China’s dynamic biotechnology landscape and global collaboration opportunities.

Conference Name: ACCESS CHINA BD Forum @BIO

Date: June 15, 2025

Content: Keynote Speeches, Panel Discussion, 10 Elevator Pitch, and Closed-Door Dinner Reception.

Participants: Pharma/Biotech senior management and BD’s

View more information at https://biotochina.org/